Investor > Company Profile

Company Profile

Founded: 2000
Headquarters: Leuven
Employees: Approx. 90
Operations: Leuven (BE): HQ, S&M, R&D, pilot production

Sittard-Geleen (NL): Production

Cambridge (UK): Biomaterials R&D

Listing: NYSE Euronext Brussels
Ticker: TIG BB
ISIN: BE0003864817
Shares outstanding: 30,866,168 (as of December 15, 2009)

Latest news


August 30, 2010: TiGenix announces the grant of a US patent for ChondroMimetic


>>>>


Events

September 9-11, 2010: AGA
(Vienna, Austria)
>>>>

Presentations

H1 2010 Results:
Download the pdf
Webcast click here
© 2010 TiGenix - Legal - Privacy policy